4//SEC Filing
Marek David C 4
Accession 0001179110-19-011011
CIK 0001579428other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:42 PM ET
Size
5.5 KB
Accession
0001179110-19-011011
Insider Transaction Report
Form 4
Marek David C
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-10-10+25,813→ 25,813 totalExercise: $17.61Exp: 2029-10-09→ Common Stock (25,813 underlying)
Footnotes (1)
- [F1]The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on October 10, 2023; provided, that the vesting of the option will be accelerated such that 100% of the option will become fully vested upon the achievement of certain clinical, operational, and/or other milestones (approved by the compensation committee) prior to, on, or about December 31, 2019.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001556914
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 4:42 PM ET
- Size
- 5.5 KB